Citable segment mix
CVS's latest SEC segment disclosure for revenue by product shows Pharmacy as the largest listed segment at $60.83B (57.7% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| Pharmacy | Jun 30, 2026 | $60.83B | 57.7% |
| Premiums | Jun 30, 2026 | $35.12B | 33.3% |
| Front Store | Jun 30, 2026 | $5.41B | 5.1% |
| Other | Jun 30, 2026 | $4.11B | 3.9% |
Source: SEC EDGAR segment disclosures; period Jun 30, 2026.
CVS company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.